Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose Tiotropium on Allergen-induced Early Asthmatic Response
NCT06679465Phase 4Not yet recruiting
- Sponsor
- University of Saskatchewan
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tiotropium in asthma, sponsored by University of Saskatchewan. Primary endpoint: Early asthmatic response. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06679465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679465.